Negative symptoms in patients with schizophrenia with special reference to the primary versus secondary distinction

Encephale

Volumn 26, Issue SPEC. ISS. 1, 2000, Pages 12-14

  Fleischhacker, Wolfgang ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Negative symptoms; Positive symptoms; Schizophrenia

Indexed keywords

ARTICLE; DELUSION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; HALLUCINATION; HUMAN; PROGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SCHIZOPHRENIA;

DELUSIONS; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; HALLUCINATIONS; HUMANS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034305597     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ANDREASEN NC. Negative symptoms in schizophrenia : definition and reliability. Arch Gen Psychiatry 1982 ; 39 : 784-8.
2. ANDREASEN NC, ROY MA, FLAUM M. Positive and negative symptoms. In : Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford : Blackwell Science Ltd, 1995 : 28-45.
3. ARNDT S, ALLIGER RJ, ANDREASEN NC. The distinction of positive and negative symptoms : the failure of a two-dimensional model. Br J Psychiatry 1991 ; 158 : 317-22.
4. BARNAS C, STUPPAECK C, MILLER C et al. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol. Int Clin Psychopharmacol 1992 ; 7: 23-7.
5. BLEULER E. Dementia praecox oder die Gruppe der Schizophrenien. Leipzig : Deuticke, 1911.
6. BOYER P, LECRUBIER Y, PUECH AJ et al. Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 1995 ; 166: 68-72.
7. BREIER A, SCHREIBER JL, DYER J et al. National Institute of Mental Health longitudinal study of chronic schizophrenia : prognosis and predictors of outcome. Arch Gen Psychiatry 1991 ; 48 : 329-46.
8. CARPENTER WT Jr, WAGMAN AMI. Deficit and nondeficit forms of schizophrenia : the concept. Am J Psychiatry 1988a ; 145 : 578-83.
9. CARPENTER WT, KIRKPATRICK B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull 1988b ; 14 : 645-59.
10. CARPENTER WT Jr. The treatment of negative symptoms : pharmacological and methodological issues. Br J Psychiatry 1996 ; 168 (Suppl 29): 17-22.
11. CROW T, CORSELLIS JAN, CROSS AJ et al. The search for changes underlying the type II syndrome in schizophrenia. In : Perris C, Struwe G, Jansson B, eds. Biological Psychiatry. Elsevier : North-Holland Biomedical Press, 1981 : 727-31.
12. DANION JM, REIN W, FLEUROT O. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Am J Psychiatry 1999 ; 156 : 610-6.
13. FLEISCHHACKER WW. Differentiation of depression, negative symptoms, and EPS in schizophrenia. J Clin Psychiatry Monograph Series 1998 ; 16(1) : 5-7.
14. GERBALDO H, FICKINGER MP, WETZEL H et al. Primary enduring negative symptoms in schizophrenia and major depression. J Psychiatr Res 1995 ; 29 : 297-302.
15. HAUSMANN A, FLEISCHHACKER WW. Diagnosis and management of depression in schizophrenia. CNS Drugs, submitted for publication, 1999.
16. HEYLEN S, LECRUBIER Y, LEONARD JP et al. Negative symptoms in schizophrenia : considerations for clinical trials. Psychopharmacology 1994; 115: 221-8.
17. HUBER G. Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr Neurol Psychiat 1996 ; 34 : 409-26.
18. KEEFE RSE, MOHS RC, LOSONCZY MF et al. Characteristics of very poor outcome schizophrenia. Am J Psychiatry 1987 ; 144 : 889-95.
19. KRAEPELIN E. Psychiatrie : ein Lehrbuch. 6. Auflage 1898, 8. Auflage. Leipzig : Barth, 1909.
20. KURZ M, HUMMER M, OBERBAUER H et al. Extrapyramidal side effects of clozapine and haloperidol. Psychopharmacology 1995 ; 118: 52-6.
21. LIBERMA RP, SPAULDING WD, CORRIGAN PW. Cognitive-behavioural therapies in psychiatric rehabilitation. In : Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford : Blackwell Science Ltd, 1995 : 605-25.
22. LIDDLE PF, BARNES TRE, MORRIS D et al. Three symptoms in chronic schizophrenia. Br J Psychiatry, 1989 ; (Suppl 7) : 119-22.
23. LÔO H, POIRIER-LITTRE MF, THERON M et al. Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia. Br J Psychiatry 1997 ; 170 : 18-22.
24. MÖLLER HJ, VAN PRAAG HM, AUFDEMBRINKE B et al. Negative symptoms in schizophrenia : considerations for clinical trials. Psychopharmacoly 1994 ; 115 : 221-8.
25. REMINGTON G, BEZCHLIBNYK-BUTLER K. Management of acute antipsychotic-induced extrapyramidal syndromes. CNS Drugs 1996 ; 5 (Suppl 1): 21-35.
26. ROBINSON DG, WOERNER MG, ALVIR JM et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999 ; 156 : 544-9.
27. SCHNEIDER K. Klinische Psychopathologie, 7. Auflage. Stuttgart : Gerog Thieme Verlag, 1996.
28. SPELLER JC, BARNES TRE, CURSON DA et al. One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistant negative symptoms. Br J Psychiatry 1997 ; 171 : 564-8.
29. VASQUEZ-BARQUERO JL, LASTRA I, CUESTA NUNEZ MJ et al. Patterns of positive and negative symptoms in first episode schizophrenia. Br J Psychiatry 1996 ; 168 : 693-701.